Tag: Cervical Cancers

New York: An improved HPV vaccine marketed by pharmaceutical giant Merck & Co has the potential to reduce 90 per cent of cervical cancers worldwide, suggest results of a major global trial. This study, published in the journal Lancet, involved more than 14,000 women in 18 countries and found that the the nine-valent human papilloma […]